BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 14, 2002
View Archived Issues
Dendreon's Trp-p8 Gene Platform Garners $110M Genentech Deal
Dendreon Corp. could gain more than $110 million in a deal with Genentech Inc. to develop monoclonal antibodies, small molecules and other products from Dendreon's preclinical Trp-p8 gene platform. (BioWorld Today)
Read More
Nobex Raises Two Year's Cash Through $35M Private Placement
Read More
GenVec's Flagship AntiCancer Drug, TNFerade, Performs Well In Both Preclinical, Clinical Trials
Read More
$37M Addition Brings Archemix Series A Financing To $51.75M
Read More
Other News To Note
Read More
CollaGenex Testing Periostat In Phase III Against Rosacea
Read More